Circulating levels of tumor necrosis factor-alpha receptor 2 are increased in heart failure with preserved ejection fraction relative to heart failure with reduced ejection fraction: evidence for a divergence in pathophysiology.
Various pathways have been implicated in the pathogenesis of heart failure (HF) with preserved ejection fraction (HFPEF). Inflammation in response to comorbid conditions, such as hypertension and diabetes, may play a proportionally larger role in HFPEF as compared to HF with reduced ejection fractio...
Main Authors: | Brendan N Putko, Zuocheng Wang, Jennifer Lo, Todd Anderson, Harald Becher, Jason R B Dyck, Zamaneh Kassiri, Gavin Y Oudit, Alberta HEART Investigators |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4055721?pdf=render |
Similar Items
-
Metabolomic fingerprint of heart failure with preserved ejection fraction.
by: Beshay N Zordoky, et al.
Published: (2015-01-01) -
Distinguishing heart failure with preserved ejection fraction from heart failure with reduced ejection fraction using proteomics techniques
by: Mbasu, Richard Juma
Published: (2016) -
Prognostic Relevance of Anxiety in Distinct Phenotypes of Heart Failure:Heart Failurewith Reduced Ejection Fraction and Heart Failure with Preserved Ejection Fraction
by: HSU, BO-CHENG, et al.
Published: (2019) -
Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis
by: Xinxin Zhang, et al.
Published: (2021-08-01) -
Approach to the Treatment of Heart Failure With Preserved Ejection Fraction and Mid-Range Ejection Fraction
by: Ewa A Jankowska, et al.
Published: (2017-01-01)